Lycopodium Limited
LYOPF
$7.24
-$1.23-14.48%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.75% | -5.55% | -5.12% | -2.91% | 1.33% |
| Total Other Revenue | 99.16% | 99.18% | -99.12% | -99.10% | -92.62% |
| Total Revenue | -3.03% | -4.85% | -5.80% | -3.60% | 0.97% |
| Cost of Revenue | -5.80% | -7.56% | -9.37% | -7.26% | 11.06% |
| Gross Profit | 6.71% | 4.71% | 3.40% | 5.82% | -23.52% |
| SG&A Expenses | 15.07% | 12.93% | 77.62% | 81.72% | 24.34% |
| Depreciation & Amortization | 11.12% | 9.05% | -2.41% | -0.13% | -4.98% |
| Other Operating Expenses | 42.94% | 40.26% | 1.72% | 4.10% | 47.39% |
| Total Operating Expenses | -1.86% | -3.70% | -7.73% | -5.57% | 12.68% |
| Operating Income | -10.60% | -12.27% | 2.41% | 4.80% | -39.58% |
| Income Before Tax | -19.81% | -21.31% | -10.03% | -7.93% | -14.52% |
| Income Tax Expenses | -15.83% | -17.40% | 3.86% | 6.29% | -4.23% |
| Earnings from Continuing Operations | -21.44% | -22.91% | -14.76% | -12.76% | -18.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 62.49% | 63.18% | -129.74% | -130.42% | -132.52% |
| Net Income | -20.50% | -21.99% | -15.75% | -13.78% | -24.26% |
| EBIT | -10.60% | -12.27% | 2.41% | 4.80% | -39.58% |
| EBITDA | -9.66% | -11.43% | 1.97% | 4.35% | -38.17% |
| EPS Basic | -20.47% | -21.96% | -15.79% | -13.85% | -24.30% |
| Normalized Basic EPS | -18.65% | -20.16% | -11.31% | -9.27% | -21.94% |
| EPS Diluted | -20.47% | -21.96% | -15.79% | -13.85% | -24.30% |
| Normalized Diluted EPS | -18.65% | -20.16% | -11.31% | -9.27% | -21.94% |
| Average Basic Shares Outstanding | -0.05% | -0.05% | 0.05% | 0.05% | 0.03% |
| Average Diluted Shares Outstanding | -0.05% | -0.05% | 0.05% | 0.05% | 0.03% |
| Dividend Per Share | -39.23% | -40.38% | -72.97% | -72.34% | -12.31% |
| Payout Ratio | -0.67% | -0.67% | 0.05% | 0.05% | 0.34% |